Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 57.44%10.28M | -91.71%614.63K | 0.00%614.63K | -33.42%18.26M | 1,443.33%3.7M | -57.73%6.53M | 15.78%7.41M | -89.38%614.63K | 48.93%27.43M | -95.08%239.87K |
| Cost of revenue | -41.44%13.56M | 67.70%23.16M | ||||||||
| Gross profit | 10.17%4.69M | -7.41%4.26M | ||||||||
| Operating expense | 52.23%9.08M | -67.79%2.14M | 52.51%3.22M | 18.04%9.17M | 74.77%6.72M | -56.83%5.97M | 6.40%6.66M | -63.29%2.11M | 4.15%7.77M | 163.51%3.84M |
| Selling and administrative expenses | ---- | ---- | ---- | -2.83%7.55M | ---- | ---- | ---- | ---- | 4.15%7.77M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | 26.94%539.61K | ---- | ---- | ---- | ---- | 4.62%425.1K | ---- |
| -General and administrative expense | ---- | ---- | ---- | -4.55%7.01M | ---- | ---- | ---- | ---- | 4.12%7.34M | ---- |
| Other operating expenses | 47.46%9.22M | -67.29%2.3M | 35.67%3.39M | -94.76%1.62M | 63.77%6.95M | -56.06%6.25M | 5.04%7.03M | -59.78%2.5M | --30.93M | --4.25M |
| Total other operating income | -51.62%138.92K | -58.31%155.42K | -55.38%174.07K | -25.28%1.28M | -41.63%234.33K | -30.44%287.16K | -14.55%372.82K | -16.70%390.11K | --1.72M | --401.45K |
| Operating profit | 112.37%1.2M | -302.92%-1.53M | -74.10%-2.6M | -27.61%-4.48M | 16.31%-3.02M | -65.38%565.04K | 422.59%753.67K | -4,022.60%-1.49M | -22.76%-3.51M | -25.06%-3.6M |
| Net non-operating interest income (expenses) | -133.73%-916.6K | -97.72%-814.27K | -23.78%-510.47K | 48.55%-1.09M | 69.07%-377.88K | 8.88%-392.16K | 0.82%-411.82K | -4.11%-412.41K | -128.99%-2.13M | -851.05%-1.22M |
| Non-operating interest income | ---- | ---- | ---- | 48.73%499.71K | ---- | ---- | ---- | ---- | 75.09%335.98K | ---- |
| Non-operating interest expense | 133.73%916.6K | 97.72%814.27K | 23.78%510.47K | -35.28%1.59M | -69.07%377.88K | -8.88%392.16K | -0.82%411.82K | 4.11%412.41K | 119.77%2.46M | 281.33%1.22M |
| Net investment income | 24.76%201.22K | -96.87%161.29K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -24.84%160.98K | 25.14%214.2K | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | ||||||||||
| Other non-operating income (expenses) | -58.06%422.5K | -39.38%1.01M | ||||||||
| Income before tax | 63.93%283.39K | -785.58%-2.34M | -63.22%-3.11M | -12.56%-4.79M | 29.66%-3.39M | -85.62%172.88K | 226.14%341.85K | -432.76%-1.91M | -229.60%-4.25M | -218.91%-4.83M |
| Income tax | -4,489.42%-438.06K | -42.16%137.64K | -74.40%96.6K | 1,283.08%620.47K | 108.01%14.75K | 76.89%-9.55K | 175.46%237.98K | 335.92%377.29K | -105.61%-52.45K | -132.21%-184.09K |
| Net income | 295.48%721.45K | -2,488.82%-2.48M | -40.49%-3.21M | -28.74%-5.41M | 26.56%-3.41M | -85.33%182.43K | 129.06%103.87K | -413.91%-2.28M | -278.96%-4.2M | -233.13%-4.64M |
| Net income continuous operations | 295.48%721.45K | -2,488.82%-2.48M | -40.49%-3.21M | -28.74%-5.41M | 26.56%-3.41M | -85.33%182.43K | 129.06%103.87K | -413.91%-2.28M | -278.96%-4.2M | -233.13%-4.64M |
| Noncontrolling interests | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to the company | 295.48%721.45K | -2,488.82%-2.48M | -40.49%-3.21M | -28.74%-5.41M | 26.56%-3.41M | -85.33%182.43K | 129.06%103.87K | -413.91%-2.28M | -278.96%-4.2M | -233.13%-4.64M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 295.48%721.45K | -2,488.82%-2.48M | -40.49%-3.21M | -28.74%-5.41M | 26.56%-3.41M | -85.33%182.43K | 129.06%103.87K | -413.91%-2.28M | -278.96%-4.2M | -233.13%-4.64M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 171.43%0.0019 | -2,350.00%-0.009 | -40.96%-0.0117 | -28.76%-0.0197 | 26.63%-0.0124 | -84.44%0.0007 | 130.77%0.0004 | -418.75%-0.0083 | -280.00%-0.0153 | -234.13%-0.0169 |
| Diluted earnings per share | 171.43%0.0019 | -2,350.00%-0.009 | -40.96%-0.0117 | -28.76%-0.0197 | 26.63%-0.0124 | -84.44%0.0007 | 130.77%0.0004 | -418.75%-0.0083 | -280.00%-0.0153 | -234.13%-0.0169 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.